Alpha-2 adrenergic receptor and imidazoline receptor (α2-adrenoceptor, I1/I2/I3 receptors)

Alpha-2 adrenergic receptors are G protein-coupled receptors (GPCRs) activated by catecholamines such as norepinephrine and epinephrine, mediating inhibition of neurotransmitter release and vasoconstriction in the central and peripheral nervous systems. They consist of three major subtypes (α2A, α2B, α2C) with distinct tissue localization and pharmacological properties. Imidazoline receptors are a distinct family of pharmacological targets, divided into I1, I2, and I3 subtypes. The I1 receptor, involved in central blood pressure regulation, is likely a GPCR and mediates hypotensive effects, while the I2 receptor serves as an allosteric binding site on mitochondrial monoamine oxidase (MAO) and may also be involved in neuroprotection, pain, and psychiatric disorders. The I3 receptor regulates insulin secretion from pancreatic β cells. Although often studied together due to overlapping ligand profiles (such as clonidine), α2-adrenoceptors and imidazoline receptors represent separate molecular entities, each with unique physiological and pharmacological roles. For pharmacological databases and modeling, these should be entered as two distinct targets: "Alpha-2 adrenergic receptor" and "Imidazoline receptor," with respective aliases and properties. The current entry combines two related but mechanistically separate families, conflating their structure and functional roles.

Other names

α2-adrenergic receptoralpha-2 ARImidazoline receptorI1 receptorI2 receptorI3 receptor

α2-adrenoceptor agonists: Decrease sympathetic outflow, lower blood pressure, induce CNS depression (sedation, analgesia), provide hemodynamic stability. Imidazoline receptor agonists (I1): Lower blood pressure by sympatho-inhibition, central reduction of sympathetic tone. Imidazoline receptor agonists (I2): Allosteric inhibition of monoamine oxidase, neuroprotection, modulation of pain states. Imidazoline receptor agonists (I3): Regulation of insulin secretion.